NEW YORK — When Dr. Alois Alzheimer first identified the disease that would bear his name in 1906, he could only confirm his diagnosis by examining brain tissue after a patient’s death. More than a ...

If further studies confirm their latest findings, Nasca says the team's research could be used to develop a blood test for dementia and for tracking the progression of Alzheimer's disease in an ...

If further studies confirm their latest findings, Nasca says the team's research could be used to develop a blood test for dementia and for tracking the progression of Alzheimer's disease in an ...

NYU researchers found that declining acetyl-L-carnitine and free carnitine levels correlate with Alzheimer’s severity, ...

The Montreal Cognitive Assessment (MoCA) is a test used to detect mild cognitive decline and early signs of dementia. It can help identify people at risk of Alzheimer's disease and screen for ...

Alzheimer’s disease could be diagnosed up to a decade earlier after the world’s biggest study of proteins is completed. The ...

The team’s goal is to define other biomarkers in the brain that track closely with Alzheimer’s disease progression. If further studies confirm their latest findings, Nasca says the team’s research ...

Dr. Nasca says that if further studies confirm their latest findings, the team's research could be used to develop a blood test for dementia and for tracking the progression of Alzheimer's disease ...

The team's goal is to define other biomarkers in the brain that track closely with Alzheimer's disease progression. If further studies confirm their latest findings, Nasca says the team's research ...

A blood test being developed by Roche and Eli Lilly that could help diagnose patients with Alzheimer’s disease more quickly has been awarded breakthrough status by the FDA, which could help it ...